Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-08-13

FDA Approved: TERIFLUNOMIDE — Supplemental Application (Glenmark Pharmaceuticals Inc., USA)

View source ↗

Summary

The FDA approved a supplemental application for teriflunomide from Glenmark Pharmaceuticals Inc., USA, enabling a generic version of the drug. Teriflunomide is …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Teriflunomide (teriflunomide)

Snippet

SUPPL AP for TERIFLUNOMIDE (TERIFLUNOMIDE)